Related Experiment Video
Updated: Jan 10, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
[Atypical pertussis: challenges in diagnosis, prevention and response strategies]
1Beijing Research Center for Respiratory Infectious Diseases/Key Laboratory of Major Diseases in Children/Ministry of Education, National Key Discipline of Pediatrics/National Clinical Research Center for Respiratory Diseases, Laboratory of Infection and Microbiology/Beijing Pediatric Research Institute/Beijing Children's Hospital, Capital Medical University/National Center for Children's Health, Beijing, 100045, China.
Abstract:
The number of pertussis cases reported through hospital-based passive surveillance severely underestimated the actual disease incidence. This may be due to factors such as atypical symptoms in the vaccine era, limited diagnostic criteria, insufficient clinician awareness, poor access to diagnostic technologies, and problems in monitoring and reporting management. Atypical pertussis often lacks specific symptoms or signs, making it prone to underdiagnosis or missed diagnosis in clinical practice. As a result, patients are not managed or treated effectively. This enables the pathogen to continue spreading. This is an important reason for the difficulty in accurately assessing the actual prevalence of pertussis. This study reviews the global understanding and evolving perspectives of atypical pertussis. It also examines the challenges this condition poses to prevention and control efforts. These challenges include low consultation rates, frequent underdiagnosis or missed diagnoses, limited laboratory testing access, and insufficiently targeted prevention strategies. The study also proposes countermeasures to optimize diagnosis, surveillance, and overall prevention and control efforts.
More Related Videos
16:56Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Steps in Outbreak Investigation
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...